drugset / Trial / NCT02823548

Primary Care Study With Chondroitin Sulfate and Glucosamine Hydrochloride in Hand Osteoarhritis

NCT02823548

Phase 4 Unknown 330 enrolled Bioiberica
RandomizedParallel-groupQuadruple-blindTreatment

Summary

PICASSO has been designed to demonstrate that combination therapy with CS/GH has superior efficacy compared to placebo in pain reduction (average score reduction in Huskisson's 0 to 100 mm Visual Analogue Scale) from baseline to 6 months of treatment in patients with symptomatic hand osteoarthritis.

Timeline

Start
2016-08
Primary completion
2017-06
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Chondroitin sulfate Unknown 1200 mg
Subject Glucosamine Small molecule 1500 mg

Indications